Filing Details
- Accession Number:
- 0001213900-16-013225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-12 17:28:45
- Reporting Period:
- 2016-05-12
- Filing Date:
- 2016-05-12
- Accepted Time:
- 2016-05-12 17:28:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1176309 | Oramed Pharmaceuticals Inc. | ORMP | Pharmaceutical Preparations (2834) | 980376008 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1351779 | Nadav Kidron | 12 Eliezer Hagadol St. Jerusalem L3 9359038 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-12 | 300 | $6.90 | 957,448 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-12 | 300 | $6.91 | 957,748 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-12 | 300 | $7.00 | 958,048 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-12 | 100 | $7.10 | 958,148 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |